GTR 110680909
Tenders Are Invited For Antineoplastic And Immunomodulating Agents – Framework Agreement For Oncological Medicines (Atezolizumab Sol.Inj. 1200Mg/20Ml)
ICB — International Competitive Bid
Closed
Eastern Europe
Tender Information
GTR Reference
110680909
Tendering Authority
Subscribe to view
Tender No
192228-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Antineoplastic And Immunomodulating Agents – Framework Agreement For Oncological Medicines (Atezolizumab Sol.Inj. 1200Mg/20Ml)
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Eastern Europe
Political Region
Balkans,European Union
Last Date of Bid Submission
27-04-2026
Closed
Work Detail
Antineoplastic And Immunomodulating Agents – Framework Agreement For Oncological Medicines (Atezolizumab Sol.Inj. 1200Mg/20Ml). Atezolizumab Sol.Inj. 1200Mg/20Ml Minimum Quantity Agreement 10 Flac., Maximum Quantity Agreement Frame 400 Flac
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
5935d0e3-aeb0-46d4-9fb3-c056337a8457.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.